Perspective Therapeutics (CATX) Revenue - Other (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue - Other (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 76,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Jun 30, 2025 | 290,000.00 |
| Mar 31, 2025 | 342,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 325,000.00 |
| Dec 31, 2023 | 337,000.00 |
| Sep 30, 2023 | 276,000.00 |
| Jun 30, 2023 | 588,000.00 |
| Mar 31, 2023 | 233,000.00 |
| Sep 30, 2011 | 50,000.00 |
| Jun 30, 2011 | 309,906.00 |
| Mar 31, 2011 | 56,118.00 |
| Dec 31, 2010 | 149,879.00 |